Sakanaka, K., Itasaka, S., Ishida, Y., Fujii, K., Horimatsu, T., Mizowaki, T., . . . Hiraoka, M. (2017). Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma. Radiat Oncol J.
Chicago Style citaatSakanaka, Katsuyuki, Satoshi Itasaka, Yuichi Ishida, Kota Fujii, Takahiro Horimatsu, Takashi Mizowaki, Yoshiharu Sakai, en Masahiro Hiraoka. "Dosimetric Advantages and Clinical Outcomes of Simultaneous Integrated Boost Intensity-modulated Radiotherapy for Anal Squamous Cell Carcinoma." Radiat Oncol J 2017.
MLA citatieSakanaka, Katsuyuki, et al. "Dosimetric Advantages and Clinical Outcomes of Simultaneous Integrated Boost Intensity-modulated Radiotherapy for Anal Squamous Cell Carcinoma." Radiat Oncol J 2017.